Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine/Midazolam vs Fentanyl/Midazolam Sedation for Interventional Radiology Procedures
NCT07040163Phase 1Active, not recruiting
- Sponsor
- CAMC Health System
- Start
- Mar 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of ketamine in sedation (2 arms), sponsored by CAMC Health System. Primary endpoint: Numeric Rating Scale pain score. Started Mar 2025; status: active, not recruiting.
02
Drugs
ketamine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT07040163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07040163.